Orano USA CEO Jean-Luc Palayer Elected to the Board of Directors for the Nuclear Energy Institute

BETHESDA, Md., January 19, 2024 – Orano USA CEO and president Jean-Luc Palayer is one of the new Board members recently announced by the Nuclear Energy Institute (NEI), the policy organization of the nuclear technologies industry, based in Washington, D.C.

With more than 20 years in the nuclear industry, Jean-Luc’s international leadership experience includes nuclear materials transportation and storage, front-end material production and deliveries, supply chain optimization, and industrial project development in the United States, Europe, and Asia.

“This is a dynamic and exciting time for the U.S. nuclear energy industry, and I am proud for this opportunity to serve on NEI’s Board helping drive and deliver impact and progress,” said Jean-Luc Palayer, CEO and president of Orano USA. “My experience and Orano’s decades of supporting U.S. utilities and federal projects provides me with unique perspective and resources to bring to the table.”

The NEI Board of Directors includes representatives from 20 nuclear utilities, major nuclear suppliers, advanced nuclear technology companies and other segments of NEI membership. NEI's members include companies that own or operate nuclear energy facilities, reactor designers and advanced technology companies, architect and engineering firms, fuel suppliers and service companies, consulting services and manufacturing companies, companies involved in nuclear medicine and nuclear industrial applications, radionuclide and radiopharmaceutical companies, universities and research laboratories, law firms, labor unions and international electric utilities.

View Jean-Luc’s LinkedIn profile and bio.

Download this press release.


About Orano
Orano USA, a regional subsidiary of Orano, is a leading supplier of nuclear fuel materials, used fuel management, advanced reactor services, decommissioning, decontamination, and radwaste treatment solutions to U.S. commercial and federal customers. Orano USA, through its subsidiary Orano Med in Texas and partner companies, is also developing cancer treatments using targeted radio-immunotherapy, with its drugs advancing through FDA-authorized clinical trials. Globally, the Orano Group provides products and services throughout the entire nuclear fuel cycle, including uranium enrichment and fuel conversion, production, packaging, transportation, storage, and reprocessing.

Media Contact: Curtis Roberts, Press Officer, 202-374-8766, curtis.roberts@orano.group

###